Assembly Biosciences, Inc. announced that Michael Samar, currently the chief financial officer, will leave the organization effective August 12, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.3 USD | -7.14% |
|
-3.90% | +45.31% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+45.31% | 90.74M | |
+7.91% | 72.21B | |
+14.98% | 9.14B | |
-23.31% | 4.33B | |
+15.70% | 4.28B | |
+32.83% | 4.15B | |
+9.28% | 2.19B | |
-33.37% | 1.98B | |
+9.30% | 1.98B | |
-46.20% | 1.68B |
- Stock Market
- Equities
- ASMB Stock
- News Assembly Biosciences, Inc.
- Assembly Biosciences, Inc. Announces Resignation of Michael Samar as Chief Financial Officer, Effective August 12, 2022